Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Commerzbank Expects Net Loss Of About EUR 720 Mln In Q4 - Update

Commerzbank AG (CRZBY.PK) Monday said it expects a net loss for its fourth quarter of 2012, which included charges related to sale of Bank Forum as well as a tax asset writedown.

On a preliminary basis, the bank expects net loss of about 720 million euros in its fourth quarter of 2012, compared to a profit of 316 million euros in the prior year.

The German bank noted that the result includes charges of 185 million euros from sale of Bank Forum and extraordinary depreciation on deferred tax accruals of around 560 million euros. In last July, Commerzbank agreed with Ukrainian Smart Group on the sale of its stake of about 96 percent in Ukraine's Bank Forum.

Commerzbank has increased its full-year 2012 operating profit to about 1,200 million euros, compared to 507 million euros in the prior year. Revenues before loan loss provisions were virtually flat at 9.9 billion euros, it added.

The company sees net profit for the year of 6 million euros, up from 638 million euros last year. The 2012 result includes extraordinary charges totaling around 980 million euros. The extraordinary charges relates mainly to charges in connection with the sale of Bank Forum of 268 million euros and depreciation on deferred tax accruals totaling 673 million euros.

Loan loss provisions advanced to around 1.7 billion euros from 1.4 billion euros in the preceding year.

As announced in November last year, Commerzbank said it will implement job cuts of 4,000 to 6,000 full-time equivalents at the Group level until 2016, and it expects to incur about 500 million euros of restructuring charges in the first quarter of 2013. The company's action is in an effort to reduce costs in material and personnel areas.

In addition, Commerzbank continues to assume it can service the silent participation of the SoFFin for the 2012 financial year.

On November 8, the lender reported a turnaround to profit in its third quarter, as the prior-year comparisons were impacted by impairment write-downs on Greek sovereign bonds.

The company would publish its detailed results for the fourth quarter and full year 2012, on February 15.

On Frankfurt's Xetra, the shares are down 3.73 percent at 1.55 euros, on a volume of 43.99 million shares.

Register
To receive FREE breaking news email alerts for Commerzbank AG and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.